GLENDA TARNOFF: Open Payments
NPI 1801958012 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 56 payments from 20 companies in 2025. Trend: 2023 $188 · 2024 $120 · 2025 $1,269
Food & beverage: $1,170Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $154 |
| SANOFI-AVENTIS U.S. LLC | 6 | $152 |
| PFIZER INC. | 8 | $151 |
| Gilead Sciences, Inc. | 4 | $117 |
| Lilly USA, LLC | 5 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| ABBVIE INC. | 5 | $77 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Novo Nordisk Inc | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $56 |
Products named: TZIELD, MOUNJARO, NURTEC ODT, Auvelity, ELIQUIS, Veozah, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
